India's Production Linked Incentive (PLI) Scheme for Medical Devices has attracted actual investments of Rs. 1,153.07 crore, with 27 projects approved under the scheme, including 14 MSMEs, according to the Ministry of Chemicals and Fertilizers.

The details were shared by Union Minister for Chemicals and Fertilizers Jagat Prakash Nadda in a written reply in the Lok Sabha on July 24, 2026.

The approved projects have commenced domestic manufacturing of high-end medical technologies.

These include MRI and CT equipment, linear accelerators (LINACs), mammography systems, C-arms, ultrasound equipment, heart valves, stents and dialysis products, marking a significant step towards reducing import dependence.

The Rs. 3,420 crore PLI scheme provides incentives for incremental sales across four key segments—cancer care and radiotherapy, radiology and imaging, anaesthetics/cardio-respiratory/renal care devices, and implants.

Till FY25, the government has released Rs. 266.64 crore as incentives under the scheme. Major beneficiaries include Wipro GE Healthcare, Siemens Healthcare, Philips, Nipro India, Meril Life Sciences and Meril Healthcare.

Among the approved projects, 23 have already been commissioned, while four are at various stages of implementation.